Updated:
Somerset Indus Capital Partners
Somerset Indus Capital Partners is a growth equity investment firm. Founded in 2014 in Mumbai, India, the firm invests in companies in pharmaceuticals, medical...
Somerset Indus Capital Partners
Somerset Indus Capital Partners is a growth equity investment firm. Founded in 2014 in Mumbai, India, the firm invests in companies in pharmaceuticals, medical devices, diagnostics, and other healthcare sectors. Somerset Indus Capital Partners has made 20 investments and had 6 portfolio exits, including NU Hospitals in December 2025 and Apex Hospitals in September 2025.
General information
Firm type
Private Equity
Year founded
2011
AUM
Undisclosed
Location
Region
Asia
Country
India
City
Mumbai
Corporate office
1501, 15th Floor, Lodha Supremus, Dr. Elijah Moses Rd, Near Worli Naka, Upper Worli, Mumbai – 400018, India
Additional offices
Bangalore, India · Mauritius
Principals
Avinash Kenkare
Team
Mayur Sirdesai
Team
Ramesh Kannan
Team
Sharad Ladha
Team
Vaibhav Doshi
Team
Zulfikar Trivedi
Team
Sector focus
Frequently asked questions
Who runs investment decisions at Somerset Indus Capital Partners?
The firm does not publicly designate a sole CIO or managing partner. The team listed on its website includes Avinash Kenkare, Mayur Sirdesai, Ramesh Kannan, and others with operating and advisory backgrounds in healthcare. Mayur Sirdesai is the named contact for its SEBI-registered funds.
Is Somerset Indus Capital Partners a generalist private equity firm?
No. Somerset invests exclusively in Indian healthcare. Its portfolio names 19 companies across diagnostics, hospitals, medtech, nutrition, and pharmaceuticals. The firm does not buy consumer, tech, or industrial businesses.
How does Somerset Indus structure its funds?
The firm uses SEBI-registered Category II Alternative Investment Funds for its domestic vehicles. Parallel structures are domiciled in Mauritius, as shown in the contact page, likely for foreign LP access. It has raised and deployed three funds to date.
How many companies has Somerset Indus exited?
Somerset's portfolio page lists at least three exited companies: Ujala Cygnus Hospitals, Express Clinics, and Sandor Medicaids. The firm notes it counts only fully exited positions in that category.
Where does Somerset Indus source its deals?
The firm leans on an advisory network that includes former senior executives from Indian healthcare companies. Its ability to execute corporate carveouts — pulling a division out of a larger entity — suggests sourcing through founder and family-owner relationships in India's hospital and pharma segments.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: